fondaparinux

Details

Instance of

type of chemical entity

Subclass of

chemical compound

active ingredient in

Arixtra

canonical SMILES

COC1C(C(C(C(O1)COS(=O)(=O)O)OC2C(C(C(C(O2)C(=O)O)OC3C(C(C(C(O3)COS(=O)(=O)O)OC4C(C(C(C(O4)C(=O)O)OC5C(C(C(C(O5)COS(=O)(=O)O)O)O)NS(=O)(=O)O)O)O)OS(=O)(=O)O)NS(=O)(=O)O)O)OS(=O)(=O)O)O)NS(=O)(=O)O

chemical formula

C₃₁H₅₃N₃O₄₉S₈

defined daily dose

2.5

has use

medication

isomeric SMILES

CO[C@H]1O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]2O[C@H]([C@@H](O[C@H]3O[C@H](COS(O)(=O)=O)[C@@H](O[C@@H]4O[C@@H]([C@@H](O[C@H]5O[C@H](COS(O)(=O)=O)[C@@H](O)[C@H](O)[C@H]5NS(O)(=O)=O)[C@H](O)[C@H]4O)C(O)=O)[C@H](OS(O)(=O)=O)[C@H]3NS(O)(=O)=O)[C@H](O)[C@H]2OS(O)(=O)=O)C(O)=O)[C@H](O)[C@H]1NS(O)(=O)=O

LiverTox likelihood score

LiverTox toxicity likelihood category E

mass

1506.951

medical condition treated

thrombosis, atrial fibrillation, thrombophlebitis, phlebitis, pulmonary embolism

physically interacts with

Serpin family C member 1

significant drug interaction

enoxaparin, dalteparin, urokinase, alteplase, tenecteplase, streptokinase, rivaroxaban, apixaban, aspirin, nabumetone, naproxen, celecoxib

subject has role

antithrombin, direct Xa inhibitor